Proventus

           Proventus

                 Improving Life - Increasing Hope

DONATE.

JOIN US.

Proventus

London

HOME PAGE.

INDEX.

REPORT.

You are encouraged to report negative side effects of prescription drugs.

DISEASES.

 

Aimspro

Unlicensed - Currently only available as a ‘special’

 

How Aimspro works

"Aimspro has been characterised biochemically and its mode of action has been determined. It is composed of a set of peptides that act to stimulate the releases and regulation of a molecular cascade that modulates the Hypothalamo-Pituitary-Adrenal (HPA) axis. In addition, Aimspro has powerful anti-inflammatory properties as it contains cytokines that induce a predominantly TH-2 anti-inflammatory profile in the patient

It has become apparent that some of the peptides in Aimspro are regulated and bound by specific carrier molecules that may regulate the action and release of their ligand and are probably necessary for the appropriate regulation and pharmacokinetics of the molecular machinery. The carrier molecules also function as a slow release mechanism, releasing bioactive components over several days."

 

It is a highly specific product obtained by vaccinating a specially selected herd of goats and then preparing the active component.

This is a powerful anti-inflammatory agent which is associated with the induction of tissue repair factors some of which are known to enhance nerve conduction.

 

Like a few dramatic developments in the pharmaceutical world the creation of Aimspro was an offshoot of a line of research looking for a treatment / cure for a specific human affliction. Since World War 2 people have been increasingly protected against many diseases by means of inoculations that involve the use of vaccines. Some that spring to mind include polio (Salk), hepatitis, meningitis, cervical cancer, smallpox, tetanus, rabies, influenza and many others. If one takes polio as an example, the Salk vaccine is produced by injecting dead polio viruses into fertilized hen’s eggs and then extracting the created antibodies produced by the embryo to counter this ‘invasion’. The antibodies are then stored as a serum in vials before injection into humans.

 

In the case of Aimspro, a solution containing totally dead HIV viruses is injected into goats (the best mammal for this job) that have to be disease-free individuals (free of BSE, scrapie, etc.). The HIV viruses are killed by two different methods and the solution is tested to make sure no live virus is present. This disease-free requirement ensures no transmission of any disease from goat to human, only antibodies. The goats are not harmed in any way; they merely provide small regular amounts of blood then go back to pasture.

 

The antibodies are officially described as “polyclonal antibodies”. They are not chemical drugs; they are classified as “biopharmaceuticals”.

 

Medical authorities have stated that antibiotics (derived from fungi) are near to the end of their useful lives due to their misuse and resistance build-up within bacteria. Although Aimspro does not work on bacteria there are many conditions that are caused by malfunctioning auto-immune systems. It is thought that these polyclonal antibodies, which have anti-inflammatory properties in such diseases, will become a major force as antibiotics become useless in the not-too-distant-future.

 

Side effects may occur:

 

 

Our members experiences - Peoples Stories

Multiple Sclerosis people who have initially shown a clinically satisfactory response to AIMSPRO go on to describe periods of marked diminution of effect, to the extent that they suspect an MS relapse has occurred. How should this be dealt with? It is important, first of all, to check whether any new medication has been commenced in recent days.

 

For example, highly important physiologically acting drugs, such as the anti-epileptic agent LAMOTRIGINE and the cardiac medication FLECAINIDE, will almost certainly antagonise the actions of AIMSPRO, so if either of these two licensed medications is indicated for medial reasons, then the administration of AIMSPRO should be temporarily suspended, rather than the other way around. Your doctor will explain this reasoning.

 

If the deterioration cannot be accounted for by the recent introduction of an antagonistic medication, then a careful search must be undertaken for a hidden focus of infection. This might come in the form of a urinary tract or pulmonary infection and I have seen this happen with both bacterial and viral causative agents. Even dental abscesses and minor wound infections can have the same effect.

 

It is very likely that the anti-inflammatory activity of AIMSPRO is diverted to these sites of active pathology. First, the infection must be treated effectively and your doctor will be the guide to what is required to achieve this. Next, the question will arise as to whether AIMSPRO should be discontinued for a time while the infection is dealt with.

 

This is also something to discuss with your doctor, but there is logic to that approach, certainly given the cost of the medication. Many patients find that attention to these matters results in a renewed palliative effect when AIMSPRO is re-commenced a few weeks later".

 

Note.

There are very important mandatory import formalities for biological products throughout the world, though the fact that a hyper immune serum is derived from a low risk country helps facilitate the necessary application process.

 

 

 

Top of Page

                                       

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

                            

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

                              

 

                             

 

                                         

 

 

 

 

 

 

 

                                                           

                                                               

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Translate